NeuroSigma, Inc. is a medical device company based in Westwood, California. NeuroSigma is focused on commercialization of its unique Trigeminal Nerve Stimulation (TNS) technology, and has a growing pipeline of treatments targeting epilepsy, depression, attention deficit hyperactivity disorder (ADHD), and post-traumatic stress disorder (PTSD). NeuroSigma is actively engaged in cutting-edge preclinical research and development, as well as groundbreaking Phase I, II, & III clinical trials.

NeuroSigma, Inc. is a medical device company based in Westwood, California. NeuroSigma is focused on commercialization of its unique Trigeminal Nerve Stimulation (TNS) technology, and has a growing pipeline of treatments targeting epilepsy, depression, attention deficit hyperactivity disorder (ADHD), and post-traumatic stress disorder (PTSD). NeuroSigma is actively engaged in cutting-edge preclinical research and development, as well as groundbreaking Phase I, II, & III clinical trials.

ATENTIV was the first company to pioneer digital therapies for behavioral disorders due to developmental delays of cognitive skills, initially for ADHD. It is combining scientific and clinical rigor, with the ingenuity of the tech industry and the power of big data analytics into a platform of products for use by providers, health care insurers and employers. Atentiv’s products deliver treatments not through a pill but through a creative and immersive action adventure video game to treat cognitive deficiencies and improve symptoms associated with behavioral disorders.

ATENTIV was the first company to pioneer digital therapies for behavioral disorders due to developmental delays of cognitive skills, initially for ADHD. It is combining scientific and clinical rigor, with the ingenuity of the tech industry and the power of big data analytics into a platform of products for use by providers, health care insurers and employers. Atentiv’s products deliver treatments not through a pill but through a creative and immersive action adventure video game to treat cognitive deficiencies and improve symptoms associated with behavioral disorders.